MarketInOut Stock Screener Log In | Sign Up

China Biotech Services Holdings Ltd

HKSE • Healthcare • Diagnostics & Research • Quote as of 10/27/2026
China Biotech Services Holdings Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeHKSE
Market Capitalization480.78 mln
Float350 mln
Earnings Date03/28/2025

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.69
Highly reliable

Relative Strength

38 / 100
Underperforming

Debt / Equity

2.14
Very high leverage

Pre-Tax Margin

-26%
Deeply loss-making

ROE

-8.60
Negative

Business Description

Founded in 1996 and based in Hong Kong, China Biotech Services Holdings Limited offers a broad range of healthcare and medical services across mainland China and Hong Kong. The company runs diagnostic laboratories, health screenings, cancer immune cell treatments, and boron neutron capture therapy, while also selling pharmaceutical products and providing insurance brokerage services. It was previously called Rui Kang Pharmaceutical Group Investments Limited before adopting its current name in November 2017.

Key Fundamentals

EPS-0.01
ROE-8.60
RPS0.09
ROIC-8.30
ROA-2.71
Interest Cover-2.50
EBITDA, mln41.45
EV / EBITDA23.53
EV / EBIT63.04
Revenue, mln71.86
EV / Revenue13.57

Quote Details

Last 0.47
Change -0.02 (-4.08%)
Open 0.49
Volume 85,000
Turnover 39,950
Average Volume 160,335

Financial Ratios

Pre-Tax Profit Margin-26
Leverage Ratio3.77
Current Ratio0.99
Price / Book3.21
Price / Tangible Book12.20
Debt / Equity2.14
Price / Sales8.36

Financial Strength

Altman Z-Score-1.24
Piotroski F-Score 4 / 9
Beneish M-Score-3.69
Price to Intrinsic Value0.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.96% 9 / 100   
1 Month -12.15% 34 / 100   
2 Months -27.69% 18 / 100   
6 Months -30.88% 32 / 100   
1 Year -52.53% 20 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog